← 產業報告目錄

Immunohematology Market Research Report by Product (Reagents, Instruments / Analyzers, and Consumables & Accessories), by Application (Blood Related Disorders, HIV), by End User (Hospitals, Diagnostic Laboratories, and Blood Banks), by Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035

出版商 Market Research Future產業別 Medical Devices出版日期 2026-05-17頁數 188報告編號 MRFRMED41118CR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

The Global Immunohematology Market was valued at USD 1,810.36 million in 2025 and is projected to reach USD 2,711.24 million by 2035. The market is expected to expand at a CAGR of 4.3% during the forecast period, driven by the growing demand for blood screening, transfusion safety, and advanced diagnostic technologies. Growing Adoption of Automated Immunohematology Analysers Drives Market Expansion The enhanced yield of the global immunohematology market is majorly attributed to the increasing installation of automated immunohematology analysers as laboratories opt for rapid, accurate, blood typing, and compatibility testing solutions. Automation reduces human error, improves laboratory efficiency, and enables high-volume testing, helping healthcare facilities meet the rising demand for safe blood transfusion services. Market Segmentation Snapshot By Product • Reagents: Essential for accurate blood grouping and compatibility testing. • Instruments / Analyzers: Enable automated, high-throughput immunohematology testing workflows. • Consumables & Accessories: Support routine laboratory operations and testing procedures. By Application • Blood Related Disorders: Facilitate diagnosis and management of hematological conditions. • HIV: Ensure safe transfusion practices through blood screening. By End User • Hospitals: Conduct transfusion testing for patient care needs. • Diagnostic Laboratories: Provide specialized immunohematology testing services. • Blood Banks: Ensure blood safety, storage, and compatibility. The North America holds the immunohematology market at the lead globally driven by advanced healthcare systems, the high frequency of blood transfusion, and the wide use of automated testing technologies. On the other hand, Europe has been the most steady performer with strong regulatory frameworks and standardized transfusion practices. Asia Pacific has been the fastest-growing market mainly due to healthcare modernization and rising blood safety awareness. Whilst South America and the Middle East & Africa are gradually expanding the market local improvements in transfusions services and laboratory automation, continuing to be the main stimuli. Strengthening Blood Screening Through Multiplex Innovation Recently, the company introduced the cobas® MPX-E assay, This is a 4-in-1 multiplex NAT test of detection of HIV, HBV, HCV, and HEV. Such innovative new blood donor screening methods render most efficient use of the physical and human resources, streamline laboratory operations, and enhance transfusion safety standards. Accelerating Laboratory Efficiency Through Automation By switching over to automated high-throughput immunohematology systems, laboratories now have the means to perform large testing volumes at high speed and with great reproducibility. This will raise the level of operational efficiency, reduce the extent of manual work, and allow healthcare providers to cope with the increasing demands for transfusion testing. Key Report Attributes • Market Size 2025: USD 1,810.36 Million • Market Size 2035: USD 2,711.24 Million • CAGR (2025-2035): 4.3% • Base Year: 2024 • Market Forecast Period: 2025-2035 Industry Segmentations Growth • By Product: Reagents - 3.8%, Instruments / Analyzers - 5.3%. • By Application: Blood Related Disorders - 4.8%, HIV - 3.0%. • By End User: Hospitals - 3.3%, Diagnostic Laboratories - 4.8%.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ..... 16 2 MARKET INTRODUCTION ....................................................... 18 2.1 DEFINITION ........................................................ 18 2.2 SCOPE OF THE STUDY .................................... 18 2.3 RESEARCH OBJECTIVE .................................. 18 2.4 MARKET STRUCTURE .................................... 19 3 RESEARCH METHODOLOGY ................................................. 20 3.1 OVERVIEW ..... 20 3.2 DATA FLOW ........................................................ 22 3.2.1 DATA MINING PROCESS ............................. 22 3.3 PURCHASED DATABASE: ............................... 23 3.4 SECONDARY SOURCES: .................................. 24 3.4.1 SECONDARY RESEARCH DATA FLOW: ............. 25 3.5 PRIMARY RESEARCH: ..................................... 26 3.5.1 PRIMARY RESEARCH DATA FLOW: ................ 27 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ................................... 28 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ........................................................ 28 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ...................................... 29 3.6.1 REVENUE ANALYSIS APPROACH .................. 29 3.7 DATA FORECASTING....................................... 29 3.7.1 DATA FORECASTING TYPE .......................... 30 3.8 DATA MODELING .............................................. 31 3.8.1 MICROECONOMIC FACTOR ANALYSIS: ............ 31 3.8.2 DATA MODELING: ..................................... 32 3.9 TEAMS AND ANALYST CONTRIBUTION ...................................................... 34 4 MARKET DYNAMICS .......... 36 4.1 INTRODUCTION ................................................. 36 4.2 DRIVERS .......... 37 4.2.1 RISING PREVALENCE OF BLOOD DISORDERS AND CHRONIC DISEASES ........................ 37 4.2.2 AUTOMATION AND TECHNOLOGICAL ADVANCEMENT ............................................. 37 4.2.3 INCREASING BLOOD DONATIONS AND TRANSFUSION PROCEDURES ............................ 38 4.3 RESTRAINTS ...................................................... 39 4.3.1 HIGH COST OF ANALYZERS & REAGENTS ....... 39 4.3.2 CULTURAL STIGMA AND UNDERDIAGNOSIS ...... 39 4.4 OPPORTUNITIES ............................................... 40 4.4.1 GROWTH OF POINT-OF-CARE TESTING (POCT) ...................................................... 40 4.4.2 INCREASING DEMAND FOR AUTOMATED HIGH-THROUGHPUT TESTING SYSTEMS .......... 40 5 MARKET DYNAMICS .......... 41 5.1 VALUE CHAIN ANALYSIS ............................. 41 5.1.1 RAW MATERIAL .................................... 41 5.1.2 MANUFACTURING / PROCESSING ......... 41 5.1.3 PACKAGING ............................................ 42 5.1.4 DISTRIBUTION ...................................... 42 5.1.5 END USER ............................................ 42 5.2 PORTER'S FIVE FORCES MODEL ................. 43 5.2.1 THREAT OF NEW ENTRANTS ......................... 43 5.2.2 BARGAINING POWER OF SUPPLIERS ..... 44 5.2.3 THREAT OF SUBSTITUTES ............................ 44 5.2.4 BARGAINING POWER OF BUYERS .................. 44 5.2.5 INTENSITY OF RIVALRY ................................ 44 6 GLOBAL IMMUNOHEMATOLOGY MARKET, BY PRODUCT ....................................................... 46 6.1 OVERVIEW ..... 46 7 GLOBAL IMMUNOHEMATOLOGY MARKET, BY APPLICATION ................................................. 49 7.1 OVERVIEW ..... 49 8 GLOBAL IMMUNOHEMATOLOGY MARKET, BY END USER ...................................................... 54 8.1 OVERVIEW ..... 54 9 GLOBAL IMMUNOHEMATOLOGY MARKET, BY REGION ..... 56 9.1 OVERVIEW ..... 56 9.2 NORTH AMERICA ............................................. 58 9.2.1 US........................................................ 61 9.2.2 CANADA ................................................ 63 9.3 EUROPE ........... 65 9.3.1 GERMANY .............................................. 68 9.3.2 UK ....................................................... 70 9.3.3 FRANCE ................................................. 72 9.3.4 NETHERLAND ........................................... 74 9.3.5 ITALY ..................................................... 76 9.3.6 SPAIN ................................................... 78 9.3.7 REST OF EUROPE ...................................... 80 9.4 ASIA PACIFIC ..................................................... 82 9.4.1 CHINA ................................................... 85 9.4.2 INDIA .................................................... 87 9.4.3 JAPAN .................................................. 89 9.4.4 SOUTH KOREA ......................................... 91 9.4.5 MALAYSIA .............................................. 93 9.4.6 THAILAND ............................................... 95 9.4.7 INDONESIA ............................................. 97 9.4.8 REST OF ASIA PACIFIC .............................. 99 9.5 SOUTH AMERICA ............................................. 101 9.5.1 BRAZIL ................................................... 105 9.5.2 MEXICO ................................................. 107 9.5.3 ARGENTINA ......................................... 109 9.5.4 REST OF SOUTH AMERICA .......................... 111 9.6 MIDDLE EAST AND AFRICA .......................... 113 9.6.1 GCC COUNTRIES ...................................... 117 9.6.2 SOUTH AFRICA ......................................... 119 9.6.3 REST OF MIDDLE EAST AND AFRICA .............. 121 10 COMPETITIVE LANDSCAPE ................................................... 124 10.1 INTRODUCTION ................................................. 124 10.2 COMPETITOR DASHBOARD........................... 125 10.3 PUBLIC PLAYERS STOCK SUMMARY ....... 126 10.4 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ......................... 126 10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES ....................................... 127 10.5.1 PRODUCT LAUNCH .................................... 127 10.5.2 ACQUISITION ....................................... 127 11 COMPANY MARKET SHARE ANALYSIS, BY COUNTRY, 2025 ................................................... 128 11.1 INTRODUCTION ................................................. 128 11.2 NORTH AMERICA MARKET SHARE ANALYSIS, BY COUNTRY 2025 ....................................................... 130 11.3 EUROPE MARKET SHARE ANALYSIS, BY COUNTRY 2025 ..................... 131 11.4 ASIA PACIFC MARKET SHARE ANALYSIS, BY COUNTRY 2025 ........... 134 11.5 SOUTH AMERICA MARKET SHARE ANALYSIS, BY COUNTRY 2025 ....................................................... 138 11.6 MIDDLE EAST AND AFRICA MARKET SHARE ANALYSIS, BY COUNTRY 2025 ................................... 140 12 COMPANY PROFILES ........ 142 12.1 THERMO FISHER SCIENTIFIC INC. ............. 142 12.1.1 COMPANY OVERVIEW ........................... 142 12.1.2 FINANCIAL OVERVIEW .......................... 143 12.1.3 PRODUCTS OFFERED ............................... 144 12.1.4 KEY DEVELOPMENTS ............................ 144 12.1.5 SWOT ANALYSIS .................................. 145 12.1.6 KEY STRATEGIES .................................. 146 12.2 ABBOTT ........... 147 12.2.1 COMPANY OVERVIEW ........................... 147 12.2.2 FINANCIAL OVERVIEW .......................... 148 12.2.3 PRODUCTS OFFERED ............................ 149 12.2.4 KEY DEVELOPMENTS ............................ 149 12.2.5 SWOT ANALYSIS .................................. 150 12.2.6 KEY STRATEGIES .................................. 151 12.3 MERCK KGAA .................................................... 152 12.3.1 COMPANY OVERVIEW ........................... 152 12.3.2 FINANCIAL OVERVIEW .......................... 153 12.3.3 PRODUCTS OFFERED ................................ 154 12.3.4 KEY DEVELOPMENTS ............................ 154 12.3.5 SWOT ANALYSIS .................................. 155 12.3.6 KEY STRATEGY ......................................... 156 12.4 F. HOFFMANN-LA ROCHE LTD .................... 157 12.4.1 COMPANY OVERVIEW ........................... 157 12.4.2 FINANCIAL OVERVIEW .......................... 158 12.4.4 KEY DEVELOPMENTS ............................ 159 12.4.5 KEY STRATEGIES .................................. 160 12.5 SIEMENS HEALTHINEERS AG ..................... 161 12.5.1 COMPANY OVERVIEW ........................... 161 12.5.2 FINANCIAL OVERVIEW .......................... 162 12.5.3 PRODUCTS OFFERED ............................... 163 12.5.4 KEY DEVELOPMENTS ............................ 163 12.5.5 KEY STRATEGIES .................................. 164 12.6 GRIFOLS, S.A. ...................................................... 165 12.6.1 COMPANY OVERVIEW ........................... 165 12.6.2 FINANCIAL OVERVIEW .......................... 166 12.6.3 PRODUCTS OFFERED ............................... 167 12.6.4 KEY DEVELOPMENTS ............................ 167 12.6.5 SWOT ANALYSIS .................................. 168 12.6.6 KEY STRATEGIES .................................. 169 12.7 BIO-RAD LABORATORIES, INC. .................... 170 12.7.1 COMPANY OVERVIEW ........................... 170 12.7.2 FINANCIAL OVERVIEW .......................... 171 12.7.3 PRODUCTS OFFERED ............................ 172 12.7.4 KEY DEVELOPMENTS ............................ 172 12.7.5 SWOT ANALYSIS .................................. 173 12.7.6 KEY STRATEGIES .................................. 174 12.8 WERFEN ......... 175 12.8.1 COMPANY OVERVIEW ........................... 175 12.8.2 FINANCIAL OVERVIEW .......................... 176 12.8.3 PRODUCTS OFFERED ................................ 176 12.8.4 KEY DEVELOPMENTS ............................ 176 12.8.5 KEY STRATEGY ......................................... 177 12.9 DANAHER CORPORATION ............................. 178 12.9.1 COMPANY OVERVIEW ........................... 178 12.9.2 FINANCIAL OVERVIEW .......................... 179 12.9.4 KEY DEVELOPMENTS ............................ 180 12.9.5 KEY STRATEGIES .................................. 181 12.10 CARDINAL HEALTH......................................... 182 12.10.1 COMPANY OVERVIEW ........................... 182 12.10.2 FINANCIAL OVERVIEW .......................... 183 12.10.3 PRODUCTS OFFERED ............................... 184 12.10.4 KEY DEVELOPMENTS ............................ 184 12.10.5 KEY STRATEGIES .................................. 185 12.11 DATA CITATIONS ............................................. 186
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 33 TABLE 2 GLOBAL IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 47 TABLE 3 GLOBAL IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 50 TABLE 4 GLOBAL IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 55 TABLE 5 GLOBAL IMMUNOHEMATOLOGY MARKET, BY REGION, 2019-2035 (USD MILLION) 57 TABLE 6 NORTH AMERICA IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 59 TABLE 7 NORTH AMERICA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 60 TABLE 8 NORTH AMERICA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 60 TABLE 9 NORTH AMERICA IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 61 TABLE 10 US IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 61 TABLE 11 US IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 61 TABLE 12 US IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 62 TABLE 13 CANADA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 63 TABLE 14 CANADA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 63 TABLE 15 CANADA IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 64 TABLE 16 EUROPE IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 66 TABLE 17 EUROPE IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 67 TABLE 18 EUROPE IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 67 TABLE 19 EUROPE IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 68 TABLE 20 GERMANY IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 68 TABLE 21 GERMANY IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 68 TABLE 22 GERMANY IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 69 TABLE 23 UK IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 70 TABLE 24 UK IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 70 TABLE 25 UK IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 71 TABLE 26 FRANCE IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 72 TABLE 27 FRANCE IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 72 TABLE 28 FRANCE IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 73 TABLE 29 NETHERLAND IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 74 TABLE 30 NETHERLAND IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 74 TABLE 31 NETHERLAND IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 75 TABLE 32 ITALY IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 76 TABLE 33 ITALY IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 76 TABLE 34 ITALY IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 77 TABLE 35 SPAIN IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 78 TABLE 36 SPAIN IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 78 TABLE 37 SPAIN IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 79 TABLE 38 REST OF EUROPE IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 80 TABLE 39 REST OF EUROPE IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 80 TABLE 40 REST OF EUROPE IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 81 TABLE 41 ASIA PACIFIC IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 83 Copyright © 2026 Market Research Future 11 TABLE 42 ASIA PACIFIC IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 84 TABLE 43 ASIA PACIFIC IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 84 TABLE 44 ASIA PACIFIC IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 85 TABLE 45 CHINA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 85 TABLE 46 CHINA IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 85 TABLE 47 CHINA IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 86 TABLE 48 INDIA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 87 TABLE 49 INDIA IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 87 TABLE 50 INDIA IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 88 TABLE 51 JAPAN IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 89 TABLE 52 JAPAN IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 89 TABLE 53 JAPAN IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 90 TABLE 54 SOUTH KOREA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 91 TABLE 55 SOUTH KOREA IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 91 TABLE 56 SOUTH KOREA IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 92 TABLE 57 MALAYSIA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 93 TABLE 58 MALAYSIA IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 93 TABLE 59 MALAYSIA IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 94 TABLE 60 THAILAND IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 95 TABLE 61 THAILAND IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 95 TABLE 62 THAILAND IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 96 TABLE 63 INDONESIA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 97 TABLE 64 INDONESIA IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 97 TABLE 65 INDONESIA IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 98 TABLE 66 REST OF ASIA PACIFIC IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 99 TABLE 67 REST OF ASIA PACIFIC IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 99 TABLE 68 REST OF ASIA PACIFIC IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 100 TABLE 69 SOUTH AMERICA IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 102 TABLE 70 SOUTH AMERICA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 103 TABLE 71 SOUTH AMERICA IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 103 TABLE 72 SOUTH AMERICA IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 104 TABLE 73 BRAZIL IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 105 TABLE 74 BRAZIL IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 105 TABLE 75 BRAZIL IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 106 TABLE 76 MEXICO IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 107 TABLE 77 MEXICO IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 107 TABLE 78 MEXICO IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 108 TABLE 79 ARGENTINA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 109 TABLE 80 ARGENTINA IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 109 TABLE 81 ARGENTINA IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 110 TABLE 82 REST OF SOUTH AMERICA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 111 TABLE 83 REST OF SOUTH AMERICA IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 111 TABLE 84 REST OF SOUTH AMERICA IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 112 TABLE 85 MIDDLE EAST AND AFRICA IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 114 Copyright © 2026 Market Research Future 12 TABLE 86 MIDDLE EAST AND AFRICA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 115 TABLE 87 MIDDLE EAST AND AFRICA IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 115 TABLE 88 MIDDLE EAST AND AFRICA IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 116 TABLE 89 GCC COUNTRIES IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 117 TABLE 90 GCC COUNTRIES IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 117 TABLE 91 GCC COUNTRIES IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 118 TABLE 92 SOUTH AFRICA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 119 TABLE 93 SOUTH AFRICA IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 119 TABLE 94 SOUTH AFRICA IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 120 TABLE 95 REST OF MIDDLE EAST AND AFRICA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 121 TABLE 96 REST OF MIDDLE EAST AND AFRICA IMMUNOHEMATOLOGY MARKET, FOR APPLICATION, 2019-2035 (USD MILLION) 121 TABLE 97 REST OF MIDDLE EAST AND AFRICA IMMUNOHEMATOLOGY MARKET, BY END USER, 2019-2035 (USD MILLION) 122 TABLE 98 PRODUCT LAUNCH 127 TABLE 99 ACQUISITION 127 TABLE 100 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERED 144 TABLE 101 ABBOTT: PRODUCTS OFFERED 149 TABLE 102 MERCK KGAA.: PRODUCTS OFFERED 154 TABLE 104 F. HOFFMANN-LA ROCHE LTD: KEY DEVELOPMENTS 159 TABLE 105 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 163 TABLE 106 GRIFOLS, S.A.: PRODUCT OFFERED 167 TABLE 107 GRIFOLS, S.A.: KEY DEVELOPMENTS 167 TABLE 108 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 172 TABLE 109 WERFEN.: PRODUCTS OFFERED 176 TABLE 111 CARDINAL HEALTH: PRODUCTS OFFERED 184 LIST OF FIGURES FIGURE 1 GLOBAL IMMUNOHEMATOLOGY MARKET: STRUCTURE 19 FIGURE 2 GLOBAL IMMUNOHEMATOLOGY MARKET: MARKET GROWTH AFFECTING FACTOR ANALYSIS (2019-2035) 36 FIGURE 3 GLOBAL IMMUNOHEMATOLOGY MARKET DRIVER: IMPACT ANALYSIS 38 FIGURE 4 PORTER'S FIVE FORCES ANALYSIS: GLOBAL IMMUNOHEMATOLOGY MARKET 43 FIGURE 5 GLOBAL IMMUNOHEMATOLOGY MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2025 & 2035 (USD MILLION) 46 FIGURE 6 GLOBAL IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2025 & 2035 (USD MILLION) 47 FIGURE 7 GLOBAL IMMUNOHEMATOLOGY MARKET SHARE (%), BY PRODUCT, 2025 48 FIGURE 8 GLOBAL IMMUNOHEMATOLOGY MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2025 & 2035 (USD MILLION) 49 FIGURE 9 GLOBAL IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2025 & 2035 (USD MILLION) 50 FIGURE 10 GLOBAL IMMUNOHEMATOLOGY MARKETSHARE (%), BY APPLICATION, 2025 50 FIGURE 11 GLOBAL IMMUNOHEMATOLOGY MARKET, END USER SEGMENT ATTRACTIVENESS, 2025 & 2035 (USD MILLION) 54 FIGURE 12 GLOBAL IMMUNOHEMATOLOGY MARKET, BY END USER, 2025 & 2035 (USD MILLION) 55 FIGURE 13 GLOBAL IMMUNOHEMATOLOGY MARKET SHARE (%), BY END USER, 2025 55 FIGURE 14 GLOBAL IMMUNOHEMATOLOGY MARKET, BY REGION, 2025 & 2035 (USD MILLION) 56 FIGURE 15 GLOBAL IMMUNOHEMATOLOGY MARKET SHARE (%), BY REGION, 2025 57 FIGURE 16 NORTH AMERICA MARKET ANALYSIS: IMMUNOHEMATOLOGY MARKET, 2019-2035 (USD MILLION) 58 FIGURE 17 NORTH AMERICA IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2025 & 2035 (USD MILLION) 59 FIGURE 18 NORTH AMERICA IMMUNOHEMATOLOGY MARKET SHARE (%), BY COUNTRY, 2025 59 FIGURE 19 EUROPE MARKET ANALYSIS: IMMUNOHEMATOLOGY MARKET, 2019-2035 (USD MILLION) 65 FIGURE 20 EUROPE MARKET ANALYSIS: IMMUNOHEMATOLOGY MARKET, 2019-2035 (USD MILLION) 65 FIGURE 21 EUROPE IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2025 & 2035 (USD MILLION) 66 FIGURE 22 ASIA-PACIFIC MARKET ANALYSIS: IMMUNOHEMATOLOGY MARKET, 2019-2035 (USD MILLION) 82 FIGURE 23 ASIA PACIFIC MARKET ANALYSIS: IMMUNOHEMATOLOGY MARKET, 2019-2035 (USD MILLION) 82 FIGURE 24 ASIA PACIFIC IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2025 & 2035 (USD MILLION) 83 FIGURE 25 SOUTH AMERICA MARKET ANALYSIS: IMMUNOHEMATOLOGY MARKET, 2019-2035 (USD MILLION) 101 FIGURE 26 SOUTH AMERICA MARKET ANALYSIS: IMMUNOHEMATOLOGY MARKET, 2019-2035 (USD MILLION) 101 FIGURE 27 SOUTH AMERICA IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2025 & 2035 (USD MILLION) 102 FIGURE 28 MIDDLE EAST & AFRICA MARKET ANALYSIS: IMMUNOHEMATOLOGY MARKET, 2019-2035 (USD MILLION) 113 FIGURE 29 MIDDLE EAST AND AFRICA MARKET ANALYSIS: IMMUNOHEMATOLOGY MARKET, 2019-2035 (USD MILLION) 113 FIGURE 30 MIDDLE EAST AND AFRICA IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2025 & 2035 (USD MILLION) 114 FIGURE 31 COMPETITOR DASHBOARD: GLOBAL IMMUNOHEMATOLOGY MARKET 125 FIGURE 32 U.S. IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 130 FIGURE 33 CANADA IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 130 FIGURE 34 GERMANY IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 131 FIGURE 35 UK IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 131 FIGURE 36 FRANCE IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 132 FIGURE 37 ITALY IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 132 FIGURE 38 SPAIN IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 133 FIGURE 39 NETHERLANDS IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 133 Copyright © 2026 Market Research Future 14 FIGURE 40 REST OF EUROPE IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 134 FIGURE 41 CHINA IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 134 FIGURE 42 INDIA IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 135 FIGURE 43 JAPAN IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 135 FIGURE 44 SOUTH KOREA IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 136 FIGURE 45 MALAYSIA IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 136 FIGURE 46 THAILAND IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 137 FIGURE 47 INDONESIA IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 137 FIGURE 48 REST OF ASIA PACIFIC IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 138 FIGURE 49 BRAZIL IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 138 FIGURE 50 MEXICO IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 139 FIGURE 51 ARGENTINA IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 139 FIGURE 52 REST OF SOUTH AMERICA IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 140 FIGURE 53 GCC COUNTRIES IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 140 FIGURE 54 SOUTH AFRICA IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 141 FIGURE 55 REST OF MIDDLE EAST AND AFRICA IMMUNOHEMATOLOGY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 141 FIGURE 56 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 143 FIGURE 57 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 145 FIGURE 58 ABBOTT.: FINANCIAL OVERVIEW SNAPSHOT 148 FIGURE 59 ABBOTT: SWOT ANALYSIS 150 FIGURE 60 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT 153 FIGURE 61 MERCK KGAA: SWOT ANALYSIS 155 FIGURE 62 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 158 FIGURE 63 SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT 162 FIGURE 64 GRIFOLS, S.A.: FINANCIAL OVERVIEW SNAPSHOT 166 FIGURE 65 GRIFOLS, S.A.: SWOT ANALYSIS 168 FIGURE 66 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 171 FIGURE 67 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS 173 FIGURE 68 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 179 FIGURE 69 CARDINAL HEALTH: FINANCIAL OVERVIEW SNAPSHOT 183

提及公司

Thermo Fisher Scientific Inc.AbbottMerck KGaAF. Hoffmann-La Roche LtdSiemens Healthineers AGGrifolsS.A.Bio-Rad LaboratoriesWerfenDanaher CorporationCardinal Health

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們